Moleculin Biotech, Inc.
MBRX
$2.41
-$0.06-2.43%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 9.13M | 9.12M | 8.87M | 8.90M | 8.87M |
| Depreciation & Amortization | 67.00K | 90.00K | 112.00K | 122.00K | 125.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 27.03M | 25.10M | 24.21M | 25.44M | 25.91M |
| Operating Income | -27.03M | -25.10M | -24.21M | -25.44M | -25.91M |
| Income Before Tax | -39.97M | -33.03M | -55.16M | -36.79M | -26.98M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -39.97 | -33.03 | -55.16 | -36.79 | -26.98 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -39.97M | -33.03M | -55.16M | -36.79M | -26.98M |
| EBIT | -27.03M | -25.10M | -24.21M | -25.44M | -25.91M |
| EBITDA | -26.97M | -25.01M | -24.10M | -25.32M | -25.78M |
| EPS Basic | -40.94 | -53.20 | -92.76 | -123.01 | -168.91 |
| Normalized Basic EPS | -25.29 | -33.22 | -57.97 | -76.88 | -105.57 |
| EPS Diluted | -40.94 | -53.20 | -92.76 | -123.01 | -168.91 |
| Normalized Diluted EPS | -25.29 | -33.22 | -57.97 | -76.88 | -105.57 |
| Average Basic Shares Outstanding | 8.49M | 4.74M | 2.70M | 1.36M | 826.10K |
| Average Diluted Shares Outstanding | 8.49M | 4.74M | 2.70M | 1.36M | 826.10K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |